New Delhi (NVI): The central government is all set to procure nearly 30 crore COVID vaccine doses from Hyderabad based firm Biological-E.
“Union Ministry of Health has finalised arrangements with Hyderabad based vaccine manufacturer Biological-E to reserve 30 crore of COVID-19 vaccine doses,” an official release said today.
Following the agreement, the Union Ministry of Health would be making an advance payment of Rs. 1500 crore to M/s Biological-E, it said.
These vaccine doses will be manufactured and stockpiled by M/s Biological-E from August-December 2021.
The COVID-19 vaccine of Biological-E is currently undergoing Phase-3 clinical trial after showing promising results in Phase 1 and 2 clinical trials.
The vaccine being developed by Biological-E is a RBD protein sub-unit vaccine and is likely to be available in the next few months.
The proposal of M/s Biological-E was examined and recommended for approval after due diligence by National Expert Group on Vaccine Administration for COVID-19 (NEGVAC), the statement read.
The arrangement with M/s Biological-E is part of the wider endeavour of Government of India to encourage indigenous vaccine manufacturers by providing them support in Research & Development (R&D) and also financial support, it added.